Colton Frazer
Colton Frazer spoke at National Society of Genetic Counselors (NSGC) Annual Conference 2026 in November 2026 (speaker, “Beyond Algorithms: How AI and Machine Learning Leverage Large-Scale Data to Inform Gene Curation and Variant Classification at Scale”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Colton. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Colton Frazer is a Senior Health Economics & Outcomes Research (HEOR) Scientist at GeneDx, where he evaluates the clinical and economic value of genetic testing to inform biopharma decision-making. He brings deep expertise in real-world evidence, outcomes research, and value demonstration, with a focus on rare and complex diseases. Prior to GeneDx, Colton was Senior Manager of HEOR at Vertex Pharmaceuticals, where he led evidence generation tactics for early pipeline products. He completed an HEOR fellowship at Agios Pharmaceuticals, applying outcomes research to novel therapeutics, particularly in rare disease. He holds a PharmD and MBA, combining scientific and business expertise to translate data into strategic insight. In addition to his industry work, Colton has served as adjunct faculty at the Saint Louis College of Pharmacy and the Massachusetts College of Pharmacy and Health Sciences, mentoring future healthcare professionals and contributing to academic research.